Veracyte (VCYT) Capital Expenditures (2016 - 2026)
Veracyte's Capital Expenditures history spans 14 years, with the latest figure at $3.8 million for Q4 2025.
- On a quarterly basis, Capital Expenditures rose 496.21% to $3.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.7 million, a 715.94% increase, with the full-year FY2025 number at $9.7 million, up 715.94% from a year prior.
- Capital Expenditures hit $3.8 million in Q4 2025 for Veracyte, down from $5.4 million in the prior quarter.
- Over the last five years, Capital Expenditures for VCYT hit a ceiling of $7.4 million in Q3 2023 and a floor of -$2.7 million in Q3 2021.
- Historically, Capital Expenditures has averaged $1.3 million across 5 years, with a median of $1.1 million in 2021.
- Biggest five-year swings in Capital Expenditures: tumbled 523.94% in 2021 and later skyrocketed 16746.67% in 2023.
- Tracing VCYT's Capital Expenditures over 5 years: stood at $5.3 million in 2021, then tumbled by 100.28% to -$15000.0 in 2022, then skyrocketed by 16746.67% to $2.5 million in 2023, then tumbled by 74.61% to $634000.0 in 2024, then surged by 496.21% to $3.8 million in 2025.
- Business Quant data shows Capital Expenditures for VCYT at $3.8 million in Q4 2025, $5.4 million in Q3 2025, and -$1.3 million in Q2 2025.